Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

TRISON RESEARCH LABORATORIES PRIVATE LIMITED

Private pharmaceutical manufacturer · Sargodha · Pakistan

Sargodha-based pharmaceutical manufacturer established in 2009 and operating from the Punjab Small Industrial Estate.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check9 Aug 2026Latest source-check date across this published portfolio
Latest effective price date29 Jul 2026Newest effective date among published current price records
Corporate profile evidence3 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Private pharmaceutical manufacturer
Address
27-A, Punjab Small Industrial Estate, Sargodha, Punjab, Pakistan
Corporate source details checked
16 Aug 2026
Corporate profile completeness
63%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000529 Trison Research Laboratories (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000529 40 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx41public portfolio records represented
REG35unique registrations represented
IDX40indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+1registry-only registrations
VER0registry-verified exact registrations
PKR40current validated price records
G20generic molecules in indexed catalogue
DF4dosage-form groups
TA7therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage98%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage95%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixTRISON RESEARCH LABORATORIES PRIVATE LIMITEDShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/trison-research-laboratories-private-limitedGenerated 24 Sep 2026Anti-infectives28 · 70%Gastrointestinal & hepatology5 · 13%Vitamins, minerals & nutrition2 · 5%Cardiovascular2 · 5%Oncology & immunology1 · 3%Respiratory & allergy1 · 3%Pain & musculoskeletal1 · 3%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioTRISON RESEARCH LABORATORIES PRIVATE LIMITEDDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/trison-research-laboratories-private-limitedGenerated 24 Sep 202640presentationsTablet15 · 38%Injection12 · 30%Suspension8 · 20%Capsule5 · 13%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionTRISON RESEARCH LABORATORIES PRIVATE LIMITEDCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/trison-research-laboratories-private-limitedGenerated 24 Sep 202638comparable productsBelow peer median12 · 32%Near peer median22 · 58%Above peer median4 · 11%Company median price position-3.5%Lowest-price equivalents1Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsTRISON RESEARCH LABORATORIES PRIVATE LIMITEDCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/trison-research-laboratories-private-limitedGenerated 24 Sep 2026Nabiqasim Industries (Pvt) Ltd.,18 shared90% overlapZafa Pharmaceutical Laboratories (P…18 shared90% overlapMediate Pharmaceutical Pvt Ltd18 shared90% overlapBosch Pharmaceuticals (Pvt) Ltd.17 shared85% overlapPharmasol (Pvt) Ltd.16 shared80% overlapBio-Labs(Pvt) Ltd16 shared80% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives28 products · 70%
Gastrointestinal & hepatology5 products · 13%
Vitamins, minerals & nutrition2 products · 5%
Cardiovascular2 products · 5%
Oncology & immunology1 products · 3%
Respiratory & allergy1 products · 3%
Pain & musculoskeletal1 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Fluoroquinolone antibacterials7 products · 18%
Third-generation cephalosporins7 products · 18%
Macrolide antibacterials7 products · 18%
Proton pump inhibitors3 products · 8%
Antimalarials3 products · 8%
Vitamins / minerals / hematinics2 products · 5%
Glycopeptide antibacterials2 products · 5%
Antiemetics2 products · 5%
Formulation footprint

Dosage forms

Tablet15 products
Injection12 products
Suspension8 products
Capsule5 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 CiproseCiprofloxacin 4presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet #2 MaksinAzithromycin 4presentations 200 mg, 250 mg · Suspension, Capsule, Tablet #3 JostleCeftriaxone 3presentations 1 g, 250 mg, 500 mg · Injection #4 PertCefotaxime 3presentations 1 g, 250 mg, 500 mg · Injection #5 TessoOmeprazole 3presentations 20 mg · Capsule #6 ThrocinClarithromycin 3presentations 125 mg/5 mL, 250 mg, 500 mg · Suspension, Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median1232% of comparable products
Near market median22within ±5% of median
Above market median411% of comparable products
Lowest-price equivalents1ties included
Company median price position -3.5% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Dicol D 5 mg/mLCholecalciferol · Injection · 5's PKR 172.47/vial/unit-20.9% vs market median Shozupril 10 mgEnalapril · Tablet · 2 x10 PKR 6.09/tablet-20.8% vs market median Lozet 2.5 mgLetrozole · Tablet · 30's PKR 369.32/tablet-9.8% vs market median Trimether 15 mg + 90 mgArtemether + Lumefantrine · Suspension · 30ml PKR 5.36/mL-8.6% vs market median Trimether 15 mg + 90 mgArtemether + Lumefantrine · Suspension · 60ml PKR 5.39/mL-7.8% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 18shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 18shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 18shared generics Bosch Pharmaceuticals (Pvt) Ltd.258 products · 74 generics 17shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 16shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 16shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers34Distinct registrations among indexed, published, presentation-validated products only
Verified price observations40
Products with a verified price40
Products with multiple price observations0
Source records with multiple versions40
Latest portfolio source check9 Aug 2026
Latest effective price date29 Jul 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

35 unique registration(s) · 40 indexed presentation(s) · 1 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Ciprose Ciprofloxacin 125 mg/5 mL Dry suspension 60ml 063302 PKR 222.36 PKR 3.71/mL Near median
Ciprose Ciprofloxacin 250 mg/5 mL Dry suspension 60ml 063303 PKR 295.45 PKR 4.92/mL Near median
Ciprose Ciprofloxacin 500 mg Tablet 1x10 063339 PKR 397.02 PKR 39.70/tablet 7% below median
Ciprose Ciprofloxacin 250 mg Tablet 1x10 063340 PKR 240.06 PKR 24.01/tablet 6% below median
Dicol D Cholecalciferol 5 mg/mL Injection 5's 124566 PKR 862.36 PKR 172.47/vial/unit 21% below median
Dicol D Cholecalciferol 5 mg/mL Injection 1's 124566 PKR 203.12 PKR 203.12/vial/unit 7% below median
Jostle Ceftriaxone 250 mg Injection 1's 045479 PKR 186.51 PKR 186.51/vial/unit Near median
Jostle Ceftriaxone 500 mg Injection 1's 045480 PKR 313.92 PKR 313.92/vial/unit Near median
Jostle Ceftriaxone 1 g Injection 1's 045481 PKR 592.75 PKR 592.75/vial/unit Near median
Lozet Letrozole 2.5 mg Tablet 30's 113757 PKR 11,079.51 PKR 369.32/tablet 10% below median
Maksin Azithromycin 200 mg Suspension 15ml 063301 PKR 304.69 PKR 20.31/mL No comparator
Maksin Azithromycin 250 mg Tablet 1x10 063330 PKR 470.88 PKR 47.09/tablet Near median
Maksin Azithromycin 250 mg Capsule 6’s 090079 PKR 282.53 PKR 47.09/capsule Near median
Maksin Azithromycin 250 mg Capsule 10’s 090079 PKR 470.88 PKR 47.09/capsule Near median
Momtek Loratadine 10 mg Tablet 1x10 032787 PKR 132.95 PKR 13.30/tablet 7% below median
Penxime Cefixime 100 mg/5 mL Suspension 30 ml 045476 PKR 314.24 PKR 10.47/mL Near median
Pert Cefotaxime 250 mg Injection 1's 045482 PKR 105.46 PKR 105.46/vial/unit Near median
Pert Cefotaxime 500 mg Injection 1's 045483 PKR 158.95 PKR 158.95/vial/unit Near median
Pert Cefotaxime 1 g Injection 1's 045484 PKR 285.88 PKR 285.88/vial/unit Near median
Qucin Levofloxacin 250 mg Tablet 1x10 063328 PKR 461.65 PKR 46.17/tablet Near median
Qucin Levofloxacin 500 mg Tablet 1x10 063329 PKR 768.18 PKR 76.82/tablet Near median
Shozupril Enalapril 10 mg Tablet 2 x10 033907 PKR 121.87 PKR 6.09/tablet 21% below median
T-Van Vancomycin 500 mg Injection 1's 124564 PKR 1,292.61 PKR 1,292.61/vial/unit 7% above median
T-Van Vancomycin 1 g Injection 1's 124565 PKR 2,086.64 PKR 2,086.64/vial/unit 11% above median
Taramol Paracetamol 500 mg Tablet 20x10’s 063338 PKR 762.93 PKR 3.81/tablet 5% above median
Temox Moxifloxacin 400 mg Tablet 5’s 090071 PKR 877.13 PKR 175.43/tablet Near median
Tesso Omeprazole 20 mg Capsule 100’s 090080 PKR 1,822.58 PKR 18.23/capsule 7% below median
Tesso Omeprazole 20 mg Capsule 10’s 090080 PKR 190.20 PKR 19.02/capsule Near median
Tesso Omeprazole 20 mg Capsule 14’s 090080 PKR 265.91 PKR 18.99/capsule Near median
Tesso 40mg InjectionRegistry verified Omeprazole sodium — — — 131752Official source ↗ No indexed price — —
Throcin Clarithromycin 125 mg/5 mL Dry suspension 60ml 063305 PKR 411.79 PKR 6.86/mL 6% below median
Throcin Clarithromycin 250 mg Tablet 1x10 063333 PKR 443.18 PKR 44.32/tablet 7% below median
Throcin Clarithromycin 500 mg Tablet 1x10 063334 PKR 821.73 PKR 82.17/tablet Near median
Trifocin Fosfomycin 250 mg Suspension 60ml 063304 PKR 166.19 PKR 2.77/mL No comparator
Trimazole Clotrimazole 500 mg Tablet 1's 063331 PKR 118.18 PKR 118.18/tablet Near median
Trimether Artemether + Lumefantrine 15 mg + 90 mg Suspension 30ml 063306 PKR 160.65 PKR 5.36/mL 9% below median
Trimether Artemether + Lumefantrine 15 mg + 90 mg Suspension 60ml 063306 PKR 323.15 PKR 5.39/mL 8% below median
Trimether Artemether + Lumefantrine 40 mg + 240 mg Tablet 8's 063332 PKR 487.50 PKR 60.94/tablet Near median
Trivon Ondansetron 8 mg/4 mL Injection 5's 124561 PKR 4,773.42 PKR 954.68/vial/unit Near median
Trivon Ondansetron 8 mg/4 mL Injection 1's 124561 PKR 954.68 PKR 954.68/vial/unit Near median
Wastatin Simvastatin 10 mg Tablet 1x10 032785 PKR 306.53 PKR 30.65/tablet 5% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). TRISON RESEARCH LABORATORIES PRIVATE LIMITED — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/company/trison-research-laboratories-private-limited/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.